Understanding IFNλ in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  de Groen, Rik A ^a   Liu, Bi Sheng ^b   Boonstra, André ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON LAMBDA; INTERFERON LAMBDA 3; INTERFERON LAMBDA 4; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN 12P40; INTERLEUKIN 28A; INTERLEUKIN 29; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; IL28A PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

CYTOKINE PRODUCTION; EDITORIAL; FIBROBLAST; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LIVER CELL; MACROPHAGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVITIS; IMMUNOLOGY; METABOLISM;

ARTHRITIS, RHEUMATOID; HUMANS; INTERLEUKINS;

EID: 84892645154     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4445     Document Type: Editorial

References (10)

1. Xu LF, Feng X, Tan W, Gu W, Guo D, Zhang M, Wang F. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients. Arthritis Res Ther 2013, 15:R170. 10.1186/ar4357, 24286242.
2. Wang F, Xu L, Feng X, Guo D, Tan W, Zhang M. Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis. Arthritis Res Ther 2012, 14:R228. 10.1186/ar4067, 3580539, 23078630.
3. Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008, 4:e1000017. 10.1371/journal.ppat.1000017, 2265414, 18369468.
4. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, Yao L, Liu H, Barahmand-pour F, Sivakumar P, Chan C, Birks C, Foster D, Clegg CH, Wietzke-Braun P, Mihm S, Klucher KM. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 2006, 44:896-906. 10.1002/hep.21312, 17006906.
5. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401. 10.1038/nature08309, 19684573.
6. Liu BS, Janssen HL, Boonstra A. IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNgamma receptor expression. Blood 2011, 117:2385-2395. 10.1182/blood-2010-07-298976, 21190998.
7. Novak AJ, Grote DM, Ziesmer SC, Rajkumar V, Doyle SE, Ansell SM. A role for IFN-λ1 in multiple myeloma B cell growth. Leukemia 2008, 22:2240-2246. 10.1038/leu.2008.263, 2771776, 18830264.
8. Megjugorac NJ, Gallagher GE, Gallagher G. Modulation of human plasmacytoid DC function by IFN-λ1 (IL-29). J Leukoc Biol 2009, 86:1359-1363. 10.1189/jlb.0509347, 19759281.
9. Kramer B, Eisenhardt M, Glassner A, Korner C, Sauerbruch T, Spengler U, Nattermann J. Do lambda-IFNs IL28A and IL28B act on human natural killer cells?. Proc Natl Acad Sci U S A 2011, 108:E519-E520. author reply E521-E522, 10.1073/pnas.1108850108, 3161529, 21825163.
10. Roelofs MF, Wenink MH, Brentano F, Abdollahi-Roodsaz S, Oppers-Walgreen B, Barrera P, van Riel PL, Joosten LA, Kyburz D, van den Berg WB, Radstake TR. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis 2009, 68:1486-1493. 10.1136/ard.2007.086421, 18765427.